Seres Therapeutics's total assets for Q2 2025 were $143.80M, a decrease of -12.41% from the previous quarter. DE:1S90 total liabilities were $110.85M for the fiscal quarter, a -2.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.